Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment Outcomes

医学 全身照射 放射治疗 回顾性队列研究 队列 放射治疗计划 核医学 外科 化疗 内科学 环磷酰胺
作者
E.R. Zhang-Velten,David Parsons,Pam Tau Lee,Eric J. Chambers,Ramzi Abdulrahman,Neil Desai,Tu Dan,Zabi Wardak,Robert Timmerman,Madhuri Vusirikala,Prapti A. Patel,Tiffany Simms-Waldrip,Victor M. Aquino,Andrew Y. Koh,Michael H. Gold,Zohaib Iqbal,You Zhang,Robert G. Reynolds,Tsuicheng Chiu,Mindy Joo,Brian Hrycushko,Luo Ouyang,Richard Lamphier,Yulong Yan,Steve B. Jiang,Kiran Kumar,Xuejun Gu
出处
期刊:Biology of Blood and Marrow Transplantation [Elsevier BV]
卷期号:28 (2): 113.e1-113.e8 被引量:6
标识
DOI:10.1016/j.jtct.2021.10.020
摘要

Total body irradiation is an important part of the conditioning regimens frequently used to prepare patients for allogeneic hematopoietic stem cell transplantation (SCT). Volumetric-modulated arc therapy enabled total body irradiation (VMAT-TBI), an alternative to conventional TBI (cTBI), is a novel radiotherapy treatment technique that has been implemented and investigated in our institution. The purpose of this study is to (1) report our six-year clinical experience in terms of treatment planning strategy and delivery time and (2) evaluate the clinical outcomes and toxicities in our cohort of patients treated with VMAT-TBI. This is a retrospective single center study. Forty-four patients at our institution received VMAT-TBI and chemotherapy conditioning followed by allogeneic SCT between 2014 and 2020. Thirty-two patients (73%) received standard-dose TBI (12-13.2 Gy in 6-8 fractions twice daily), whereas 12 (27%) received low-dose TBI (2-4 Gy in one fraction). Treatment planning, delivery, and treatment outcome data including overall survival (OS), relapse-free survival (RFS), and toxicities were analyzed. The developed VMAT-TBI planning strategy consistently generated plans satisfying our dose constraints, with planning target volume coverage >90%, mean lung dose ∼50% to 75% of prescription dose, and minimal hotspots in critical organs. Most of the treatment deliveries were <100 minutes (range 33-147, mean 72). The median follow-up was 26 months. At the last follow-up, 34 of 44 (77%) of patients were alive, with 1- and 2-year OS of 90% and 79% and RFS of 88% and 71%, respectively. The most common grade 3+ toxicities observed were mucositis (31 patients [71%]) and nephrotoxicity (6 patients [13%]), both of which were deemed multifactorial in cause. Four patients (9%) in standard-dose cohort developed grade 3+ pneumonitis, with 3 cases in the setting of documented respiratory infection and only 1 (2%) deemed likely related to radiation alone. VMAT-TBI provides a safe alternative to cTBI. The dose modulation capability of VMAT-TBI may lead to new treatment strategies, such as simultaneous boost and further critical organ sparing, for better malignant cell eradication, immune suppression, and lower toxicities.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
天才发布了新的文献求助10
1秒前
2秒前
衣锦夜行完成签到,获得积分10
4秒前
完美世界的应助被是小鱼采纳,获得10
4秒前
汉堡包的应助被11NING采纳,获得10
4秒前
hanks完成签到,获得积分10
5秒前
Largequail完成签到,获得积分10
6秒前
啦啦啦发布了新的文献求助10
6秒前
衣锦夜行发布了新的文献求助10
8秒前
李爱国的应助被乐观阑悦采纳,获得10
8秒前
李健的应助被合适的咖啡采纳,获得10
8秒前
Savananh_Xie发布了新的文献求助10
8秒前
啦啦啦啦啦完成签到 ,获得积分10
8秒前
9秒前
Aria完成签到,获得积分10
10秒前
10秒前
若即若离完成签到,获得积分10
11秒前
yeo完成签到 ,获得积分10
12秒前
回眸完成签到 ,获得积分10
12秒前
zz发布了新的文献求助10
13秒前
sun完成签到,获得积分10
13秒前
张伟的应助被是我呀吼采纳,获得10
13秒前
深情安青的应助被Zzha10采纳,获得10
13秒前
Kris完成签到 ,获得积分10
14秒前
无穷爱科研完成签到,获得积分10
14秒前
yao完成签到,获得积分10
15秒前
慕青的应助被xwx采纳,获得10
16秒前
hanks发布了新的文献求助10
16秒前
爱火未灭完成签到,获得积分10
16秒前
17秒前
跳跃完成签到,获得积分10
17秒前
yeo关注了科研通微信公众号
17秒前
ll完成签到,获得积分10
18秒前
20秒前
白啊白完成签到,获得积分20
20秒前
眼睛大的棒棒糖完成签到,获得积分20
21秒前
大华发布了新的文献求助30
22秒前
紫亦君完成签到,获得积分10
22秒前
22秒前
努力的小天完成签到 ,获得积分10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181658
求助须知:如何正确求助?哪些是违规求助? 9571454
关于积分的说明 21818081
捐赠科研通 7777987
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479568